COMMUNIQUÉS West-GlobeNewswire

-
Mesa Laboratories, Inc. to Announce Third Quarter Results on February 4, 2025
17/01/2025 - 19:15 -
GUERBET : Bilan semestriel du contrat de liquidité
17/01/2025 - 18:00 -
Bionet America, Inc. Launches Super Air Smart ICU
17/01/2025 - 17:28 -
Abacus Analytics Receives HFMA Peer Review Designation
17/01/2025 - 16:30 -
Legend Senior Living Announces Expansion in Pittsburgh
17/01/2025 - 16:23 -
Enthea to Present at the 2025 Sequire Investor Summit in Puerto Rico
17/01/2025 - 15:00 -
Autonomix Medical, Inc. Finalizes Design of ASIC Microchip for Sensing Technology Catheter for Use in Humans, Continuing Progress Toward a U.S. Pivotal Trial in 2025
17/01/2025 - 14:00 -
Novo Nordisk A/S: Semaglutide 7.2 mg s.c. achieved 20.7% weight loss in the STEP UP obesity trial, and 18.7% regardless of treatment adherence
17/01/2025 - 13:11 -
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
17/01/2025 - 13:00 -
Enovis™ Announces Leadership Change to International Surgical Business
17/01/2025 - 12:00 -
Immuron Travelan® continued strong sales growth
17/01/2025 - 12:00 -
Junshi Biosciences Announces Toripalimab’s Approval in Australia
17/01/2025 - 11:56 -
Digbi Health Expands its Multi-Condition Care Platform to Enhance Efficacy and Adherence to GLP-1 Drugs
17/01/2025 - 11:21 -
ProstaVive: Introducing ProstaVive as the New Standard of Prostate Support in 2025
17/01/2025 - 08:18 -
IBA announces Chief Financial Officer transition
17/01/2025 - 07:00 -
IBA annonce une transition dans sa direction financière
17/01/2025 - 07:00 -
Foundation for Sarcoidosis Research Warns of Increased Risk of Sarcoidosis from Fire and Smoke Exposure Urging Immediate Action to Prevent Future Health Consequences
17/01/2025 - 00:43 -
Laguna Treatment Center Pilots Value-Based Care with Magellan Health, Leading the Way for Better Patient Outcomes in Addiction Treatment
16/01/2025 - 23:30 -
Illuccix® Receives European Approval
16/01/2025 - 23:06
Pages